NASDAQ:AMLX

Amylyx Pharmaceuticals Stock Forecast

etoro logo Buy AMLX
*Your capital is at risk
$22.67
-0.150 (-0.657%)
At Close: Aug 10, 2026

Should you buy AMLX stock?

Last updated:

Based on market data through , StockInvest.us rates Amylyx Pharmaceuticals, Inc. (AMLX) as a Buy Candidate with a technical score of 3.53 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.

  • Buy signal since
  • Price since signal Up 55.38%
  • 3-month trend forecast Up 56.49%
  • Buy Candidate 3.53
AI Analysis AI Analysis of AMLX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add AMLX to Watchlist?
Some Reasons Why To Add AMLX:
  • +189.9% price growth over the last year
  • Lower volatility than the market (beta -0.20)
  • +98.5% YTD performance
PDF

Amylyx Pharmaceuticals, Inc. stock price ended at $22.67 on Monday, after losing 0.657%
(Market data through Aug 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Jun 12, 2026 Gain 55.38%

The Amylyx Pharmaceuticals, Inc. stock price fell by -0.657% on the last day (Monday, 10th Aug 2026) from $22.82 to $22.67. During the last trading day the stock fluctuated 4.64% from a day low at $22.00 to a day high of $23.02. The price has been going up and down for this period, and there has been a 16.32% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -1 million shares and in total, 1 million shares were bought and sold for approximately $29.17 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 56.49% during the next 3 months and, with a 90% probability hold a price between $29.95 and $38.30 at the end of this 3-month period.

AMLX Signals & Forecast

The Amylyx Pharmaceuticals, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $21.98 and $18.83. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, August 06, 2026, and so far it has fallen -6.28%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Amylyx Pharmaceuticals, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $20.75 and $17.79. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Amylyx Pharmaceuticals, Inc. finds support just below today's level at $20.75. If this is broken, then the next support from accumulated volume will be at $17.79 and $17.44.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.02 between high and low, or 4.64%. For the last week, the stock has had daily average volatility of 8.36%.

Our recommended stop-loss: $21.40 (-5.60%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 2 days ago.)

Trading Expectations (AMLX) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Amylyx Pharmaceuticals, Inc. to open at $22.56, and during the day (based on 14 day Average True Range), to move between $21.99 and $23.35, which gives a possible trading interval of +/-$1.35 (+/-6.15%) up or down from last closing price. If Amylyx Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 6.15% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $22.82 (0.66%) than the support at $20.75 (8.47%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Amylyx Pharmaceuticals, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Amylyx Pharmaceuticals, Inc. stock to perform well in the short-term.

Current score: 3.525 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $22.56 ( 0.471%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

AMLX Performance

Trading levels for AMLX

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 23.58 4.03%
R2 23.19 2.31%
R1 22.95 1.25%
Price 22.67
S1 22.17 -2.19%
S2 21.93 -3.25%
S3 21.54 -4.97%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 24.19 6.70%
R1 22.82 0.662%
Price 22.67
S1 20.75 -8.47%
S2 17.79 -21.53%
S3 17.44 -23.07%

AMLX Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jan 25, 2018 Mar 28, 2018 Apr 02, 2018 $0.420 0%
2 Dec 28, 2017 Dec 28, 2017 Jan 02, 2018 $0.360 0%
3 Sep 28, 2017 Sep 28, 2017 Oct 02, 2017 $0.240 0%

FAQ

What is the symbol for Amylyx Pharmaceuticals, Inc. Stock and on which exchange is it traded?
The symbol for Amylyx Pharmaceuticals, Inc. is AMLX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Amylyx Pharmaceuticals, Inc. Stock?
Based on market data through Aug 10, 2026, StockInvest.us rates Amylyx Pharmaceuticals, Inc. (AMLX) as a Buy Candidate with a technical score of 3.53 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation. Since the Buy signal began on Jun 12, 2026, the price has risen 55.38%. The current 3-month trend forecast projects a rise of 56.49%.

How to buy Amylyx Pharmaceuticals, Inc. Stock?
Amylyx Pharmaceuticals, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Amylyx Pharmaceuticals, Inc. Stock.

What's the current price of Amylyx Pharmaceuticals, Inc. Stock?
As of the end of day on the Aug 10, 2026, the price of an Amylyx Pharmaceuticals, Inc. (AMLX) share was $22.67.

What is the 52-week high and low for Amylyx Pharmaceuticals, Inc. Stock?
The 52-week high for Amylyx Pharmaceuticals, Inc. Stock is $24.60 and the 52-week low is $7.61.

What is the market capitalization of Amylyx Pharmaceuticals, Inc. Stock?
As of the Aug 10, 2026, the market capitalization of Amylyx Pharmaceuticals, Inc. is 2.521B.
Click to get the best stock tips daily for free!
ABOUT AMYLYX PHARMACEUTICALS, INC.
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosis. It is also developing AMX0035 for other neurodegenerative diseases. ...
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE